Novo Nordisk AS (NVO)
110.08
-1.86
(-1.66%)
USD |
NYSE |
Nov 04, 13:00
Novo Nordisk Gross Profit Margin (Quarterly): 84.90% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 84.90% |
| March 31, 2024 | 84.83% |
| December 31, 2023 | 84.80% |
| September 30, 2023 | 83.46% |
| June 30, 2023 | 85.53% |
| March 31, 2023 | 84.67% |
| December 31, 2022 | 82.82% |
| September 30, 2022 | 84.20% |
| June 30, 2022 | 85.29% |
| March 31, 2022 | 83.54% |
| December 31, 2021 | 83.72% |
| September 30, 2021 | 82.99% |
| June 30, 2021 | 83.21% |
| March 31, 2021 | 82.81% |
| December 31, 2020 | 82.52% |
| September 30, 2020 | 83.33% |
| June 30, 2020 | 84.10% |
| March 31, 2020 | 84.10% |
| December 31, 2019 | 83.24% |
| September 30, 2019 | 83.24% |
| June 30, 2019 | 83.86% |
| March 31, 2019 | 83.84% |
| December 31, 2018 | 84.35% |
| September 30, 2018 | 84.10% |
| June 30, 2018 | 84.12% |
| Date | Value |
|---|---|
| March 31, 2018 | 84.42% |
| December 31, 2017 | 83.21% |
| September 30, 2017 | 83.95% |
| June 30, 2017 | 84.60% |
| March 31, 2017 | 85.06% |
| December 31, 2016 | 83.37% |
| September 30, 2016 | 85.52% |
| June 30, 2016 | 85.27% |
| March 31, 2016 | 84.44% |
| December 31, 2015 | 84.04% |
| September 30, 2015 | 85.64% |
| June 30, 2015 | 85.74% |
| March 31, 2015 | 84.63% |
| December 31, 2014 | 83.73% |
| September 30, 2014 | 84.60% |
| June 30, 2014 | 83.03% |
| March 31, 2014 | 82.96% |
| December 31, 2013 | 84.33% |
| September 30, 2013 | 82.81% |
| June 30, 2013 | 83.13% |
| March 31, 2013 | 81.94% |
| December 31, 2012 | 84.96% |
| September 30, 2012 | 82.44% |
| June 30, 2012 | 82.41% |
| March 31, 2012 | 80.83% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.52%
Minimum
Dec 2020
85.53%
Maximum
Jun 2023
83.90%
Average
83.72%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
| Evaxion Biotech AS | -- |
| Amgen Inc | 61.07% |
| Viking Therapeutics Inc | -- |
| Adaptimmune Therapeutics PLC | -- |
| Genfit SA | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 89.79% |
| Return on Assets | 28.81% |
| Return on Invested Capital | 68.37% |
| Profit Margin (Quarterly) | 29.46% |
| Operating Margin (Quarterly) | 38.10% |
| Return on Net Operating Assets | 32.70% |